Quantcast
Last updated on April 24, 2014 at 13:15 EDT

Latest Leukemia & Lymphoma Society Stories

2013-12-10 12:33:00

Annual Conference Will Share Latest Advances in Blood Cancer Research and Clinical Trials SAN FRANCISCO, Dec. 10, 2013 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter will be hosting its annual Emerging Therapies & Survivorship Conference for blood cancer patients on Saturday, January 25, 2014, from 8:30 a.m. to 12:30 p.m. PT at the Hyatt Regency San Francisco. The Emerging Therapies & Survivorship Conference is a free event...

2013-12-05 23:00:47

Rafael Hernandez exemplifies the spirit of community engagement that has been a guiding principle of MedMar Healing Center from day one. In addition to running marathons, Hernandez and others at MedMar have organized blood drives, removed trash from area waterways, and collected canned food for the local homeless population. (PRWEB) December 05, 2013 MedMar Healing Center staff are pleased to announce that one of the dispensary’s co-founders, Rafael Hernandez, has invested a generous...

2013-12-05 12:29:45

WHITE PLAINS, N.Y., Dec. 5, 2013 /PRNewswire/ -- Many researchers funded by The Leukemia & Lymphoma Society (LLS) will be among those presenting exciting new directions in blood cancer research at the 55th American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans in early December. The meeting takes place from December 7-10 at the Ernest N. Morial Convention Center. Advances in immune-stimulating therapies, moleculary-targeted drug therapies, including...

2013-12-05 12:28:53

WHITE PLAINS, N.Y., Dec. 5, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) today is pleased to announce Gregory Reaman, M.D., associate director for oncology sciences with the office of hematology and oncology products of the U.S. Food and Drug Administration (FDA), will be presented with the prestigious Return of the Child Award at a reception at the New Orleans Marriott on December 6, 2013. The Return of the Child Award honors an individual who has made a major and...

2013-12-02 23:22:04

Palm Harbor-based Nationwide Title Clearing, Inc. (NTC) participated in the Light the Night Walk, the Leukemia & Lymphoma Society’s annual fundraiser, in a company-wide CSR effort. Palm Harbor, FL (PRWEB) December 02, 2013 Nationwide Title Clearing, Inc. (NTC), a leading research and document production company, recently participated in the Leukemia and Lymphoma Society’s “Light the Night Walk” fundraising event. The charity walk, which is hosted in nearly two hundred...

2013-11-25 08:27:18

LLS Brand Platform -- Someday is Today -- Adds Call to Action to Raise Awareness of Need for Blood Cancer Cures WHITE PLAINS, N.Y., Nov. 25, 2013 /PRNewswire/ -- As the leading global nonprofit dedicated to finding cures and ensuring access to treatments for blood cancer patients, The Leukemia & Lymphoma Society (LLS) is building on the successful launch of its Someday is Today brand platform by asking the public to Declare It. Cancer Ends With Me - a strong call for consumers to...

2013-11-21 16:26:24

Proceeds of Sale of Jacques Lowe Photographs of Former First Lady Jacqueline Kennedy to Benefit LLS Mission WHITE PLAINS, N.Y., Nov. 21, 2013 /PRNewswire/ -- A striking collection of framed photographs owned by The Leukemia & Lymphoma Society (LLS) of former First Lady Jacqueline Kennedy, both alone and accompanied by President John Kennedy, and other family members, is part of a major auction taking place in Amesbury, Mass., to commemorate the 50(th) anniversary of the...

2013-11-14 16:25:28

Esten Makes Daytime "Millionaire" History by Becoming the First Celebrity Contestant Ever to Make it all the Way to the $1 Million Question! NEW YORK, Nov. 14, 2013 /PRNewswire/ -- Actor Charles Esten, who portrays Deacon Claybourne on the hit ABC series "Nashville," will appear as a contestant on "Who Wants To Be A Millionaire" with new host Cedric "The Entertainer" in episodes airing Wednesday, November 20 and Thursday, November 21, and will donate his winnings to The Leukemia...

2013-11-13 16:26:31

Ibrutinib becomes second drug with 'breakthrough therapy designation' approved by FDA WHITE PLAINS, N.Y., Nov. 13, 2013 /PRNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of ibrutinib to treat patients with mantle cell lymphoma (MCL) is a significant advance for patients with this blood cancer. It was approved as a single agent for treatment of patients with MCL who have received at least one prior therapy. Ibrutinib is the second drug with "breakthrough...

2013-11-04 16:28:32

WHITE PLAINS, N.Y., Nov. 4, 2013 /PRNewswire/ -- The U.S. Food and Drug Administration's approval of Gazyva® (obinutuzumab) is an important advance for patients diagnosed with chronic lymphocytic leukemia (CLL). Gazyva, the first treatment approved through the FDA's breakthrough therapy designation, is indicated in combination with chlorambucil to treat previously untreated patients with CLL. Breakthrough therapy designation is granted if preliminary clinical evidence indicates the...